How Is a GLP-1 Lift Different from a Facelift
Learn More A once-weekly, lower-dose dual agonist (GLP-1/GIP) designed for a gentler start and to minimize side effects
Why Are GLP-1 Drug Prices Rising So Fast
Most of these changes are harmless and correct themselves within a few hours
More recently, long-acting GLP-1 RAs for obesity have been approved: semaglutide (approved in 2021), resulted in an average weight reduction of around 15% 1214 , and tirzepatide (approved in 2023), demonstrating an average weight reduction of approximately 20% 1517
This article explores what GLP-1 is, how GLP-1 patches claim to work, what scientific research currently shows, and which alternatives are supported by stronger evidence